Can Subsense’s Nanoparticles Be One Small Step for BCI; Preview of the MedtechVISION Conference

In this episode of the DeviceTalks Weekly Podcast, Subsense CEO and Co-Founder Tetiana Aleksandrova shares how her company is using nanoparticles to establish brain-computer interfaces with the potential to deliver powerful new therapies to the brain. In her conversation with Host Tom Salemi, she reflects on her background, the impact of the war in her native Ukraine, and her previous work on neural interfaces. Earlier in the episode, AcuityMD Co-Founder and CEO Michael Monovoukas offers a look at the future of MedTech innovation (FOMO) in a conversation with Managing Editor Kayleen Brown. This episode is brought to you by AcuityMD. Learn more at www.acuitymd.com. Also, Yvonne Bokelman, Executive Director of MedtechWOMEN, previews the upcoming MedtechVISION conference taking place Sept. 9. Register at MedtechWOMEN.org. Finally, MassDevice Editor Chris Newmarker delivers his Newmarkers Newsmakers, featuring updates on Modular Medical, SetPoint Medical, Boston Scientific, Nyxoah, and OpenAI. Thank you for listening to the DeviceTalks Weekly podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:20) - Newmarkers Newsmakers(00:06:21) - Modular Medical(00:08:18) - SetPoint Medical(00:10:14) - Boston Scientific(00:12:38) - Nyxoha(00:14:08) - OpenAI(00:16:22) - FOMO with Michael Monovoukas of AcuityMD(00:28:12) - Yvonne Bokelman, Executive Director, MedtechWOMEN(00:43:02) - Tetiana Aleksandrova, Co-Founder and CEO, Subsense(00:46:47) - Her origins/thoughts on the Russian invasion of her native Ukraine(00:52:18) - Origin of Subsense(00:56:20) - Nanoparticle technology(00:59:54) - Role of the nanoparticles